2 New High-Growth Stocks for You

Two of Cramer’s once favorite high-growth stocks have failed to live up to his expectations, so he’s telling viewers to cash out and try two new picks instead.

Intuitive Surgical and Express Scripts , members of Cramer’s C.A.N.D.I.E.S. group of momentum names, which included Chipotle , Apple , Netflix , Deckers Outdoor and Salesforce.com as well, have lagged the others. While the C.A.N.D.I.E.S. have delivered double the gains of the S&P 500 since Cramer first created the list back on June 3, the former coming in at 16 percent, these two are down 21 percent and 3 percent, respectively.

Cramer’s switching out ISRG and ESRX for F5 Networks and Amazon.com , making a new acronym worth remembering: F.A.D.S. C.A.N.

What’s that mean? Well, a good part of the reason Chipotle, Apple, Netflix, Deckers Outdoor and Salesforce.com are up so much is because the analysts underestimate them. They think the stocks are part of a mere fad, short-term trends that will peter out eventually. What they don’t realize, though, is that a legitimate secular shift is taking place among both consumers and corporations, and that is what will drive these companies’ growth going forward.

Chipotle’s making fast food healthy. Apple, with its iPhone and iPad, is changing the way we communicate, and drawing more and more people to its Mac computers in the process. Netflix is revolutionizing the way we watch TV. And so on and so on. These are “broad, new, uncharted” market opportunities, Cramer said.

Where do F5 and Amazon fit in? The first is at the sweet spot among a shrinking data-center market, a growing cloud-computing one and the boom in the Internet and mobile traffic. Hence its great quarter reported Oct. 26. And Amazon has gone from being a mere online seller of books and music to the Walmart of the Internet. It is “a company that’s transforming the way we shop,” Cramer said.

Unfortunately for Intuitive Surgical, there are only so many Da Vincis the company can sell. These are the cutting-edge surgical machines that allow for patients to leave the hospital quicker, but hospitals in this economy just can’t afford them. Express Scripts is a play on branded drugs going off patent, but few will do so until late 2011. Therefore, there’s no reason to own the stock until then.

The way Cramer sees it, the best way to find profits in this market is through high-growth stocks.

That’s why the F.A.D.S. C.A.N. “are still buys even up here,” he said, “and it's why they’ll stay that way.”

When this story published, Cramer's charitable trust owned Apple.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com